Find out why Capecitabine (Xeloda) is hard to find in 2026, what's causing supply issues, and what cancer patients can do to get their prescription filled.
You've been told you need Capecitabine — a critical chemotherapy medication — and your pharmacy says it's out of stock. Now what? This is a situation thousands of cancer patients across the United States have faced over the past few years, and it can feel overwhelming when you're already dealing with a cancer diagnosis.
Capecitabine, sold under the brand name Xeloda, is one of the most commonly prescribed oral chemotherapy drugs in the country. It's used to treat breast cancer, colon cancer, rectal cancer, pancreatic cancer, and gastric cancer. When patients can't find it, treatment delays can have real consequences.
In this article, we'll explain what Capecitabine is, why it has been so difficult to find, and — most importantly — what you can do about it right now.
Capecitabine is an oral chemotherapy medication that belongs to a class of drugs called fluoropyrimidine antimetabolites. It works as a prodrug — meaning it gets converted into its active form, 5-fluorouracil (5-FU), inside your body. What makes Capecitabine unique is that this conversion happens preferentially in tumor cells, which helps target the cancer more directly.
It comes in two tablet strengths: 150 mg and 500 mg. Patients typically take it twice a day for 14 days, followed by a 7-day rest period, in repeating 21-day cycles. It's taken within 30 minutes after breakfast and dinner with a full glass of water.
To learn more about how this drug works in your body, check out our guide on how Capecitabine works.
There are several reasons why Capecitabine has been difficult to locate at pharmacies, especially since 2023. Here are the main factors:
Starting in 2023, the United States experienced one of the worst oncology drug shortages in recent history. Capecitabine was one of 15 key cancer drugs affected by this crisis. The shortage was driven by manufacturing disruptions at key production facilities, increased global demand for cancer medications, and supply chain vulnerabilities that had been building for years.
While the worst of the crisis eased by late 2024, the effects have lingered into 2026, with some pharmacies still experiencing intermittent supply gaps.
Although generic Capecitabine is available from several companies — including Teva, Mylan, Sun Pharma, and Accord Healthcare — the number of manufacturers is still relatively small for a drug this important. When even one manufacturer has a production issue, it creates a ripple effect across the entire supply chain.
Capecitabine is classified as an oral oncology medication, and many insurance plans require it to be dispensed through specialty pharmacies rather than regular retail pharmacies. This means your local pharmacy may not routinely stock it, even when supply is adequate nationally.
Some insurance plans require prior authorization before covering Capecitabine. These administrative delays can make it feel like the drug is unavailable when, in reality, the hold-up is on the insurance side. By the time approval comes through, the pharmacy's limited stock may have already been dispensed to other patients.
If you're having trouble finding Capecitabine, don't panic. There are several practical steps you can take:
Tools like Medfinder can help you search for pharmacies near you that have Capecitabine in stock. Instead of calling pharmacy after pharmacy, you can check availability in real time.
Large chain pharmacies often get the most attention, but independent and specialty pharmacies may have different supply channels. They sometimes have stock when the big chains don't. Ask your oncologist's office for recommendations — they often know which local pharmacies carry oral chemo drugs.
If Capecitabine is truly unavailable, your oncologist may be able to prescribe an alternative. Intravenous 5-Fluorouracil (5-FU) provides the same active compound but requires infusion at a cancer center. Other options like Trifluridine/Tipiracil (Lonsurf) may be appropriate depending on your cancer type. Read more in our article on alternatives to Capecitabine.
If you're prescribed brand-name Xeloda, Genentech's Access to Care Foundation may be able to help you locate supply or access the medication at no cost if you meet eligibility requirements.
It's important not to simply skip your chemotherapy doses while waiting for a refill. Contact your oncologist immediately if you're running low — they can often access supply through their clinic or hospital pharmacy that isn't available to retail patients.
For more detailed tips, see our guide on how to find Capecitabine in stock near you.
Finding Capecitabine shouldn't be a second battle on top of your cancer diagnosis. While supply has improved significantly since the worst of the 2023 shortage, some patients still face challenges locating this essential medication. The good news is that you have options — from pharmacy locator tools to alternative medications to patient assistance programs.
If you're struggling to find Capecitabine, Medfinder can help you locate pharmacies with stock near you. And don't hesitate to lean on your oncology team — they deal with these supply challenges every day and can help you navigate them.
For more information about this medication, read our complete overview: What Is Capecitabine? Uses, Dosage, and What You Need to Know.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
